InVisionFirst®-Lung (Liquid Biopsy)

What is InVisionFirst®- Lung (Liquid Biopsy)?

At NeoGenomics, we understand that you may have a lot of questions about living with advanced non-small cell lung cancer (aNSCLC). We’re here to offer information, answers, and support.

InVisionFirst®-Lung is a liquid biopsy (blood) test that can detect cancer cells within the body1

Just as we are all individuals, your aNSCLC is unique to you. As an important part of understanding your cancer and offering you the best care, your doctor may recommend a test called a biopsy.1 A biopsy can help your cancer care team identify specific markers within your cancer that could be a good target for personalized treatment.1,2 There are different types of biopsies:1

  • In a tissue biopsy, a specialist doctor removes a small sample of your tumor and looks at it under a microscope. Their goal is to closely assess the sample and gain more insights into your specific cancer.1
  • If there’s not enough tissue, or there’s a medical reason a tissue biopsy can’t be done, you may receive a test called liquid biopsy.2 Here, a sample of blood is used to help identify if there are any cancer cells circulating in your body.1

Your care team may also use both tissue and liquid biopsies to help get a complete picture of what’s going on in your body.2

InVisionFirst®-Lung is a liquid biopsy (blood) test used to help you and your care team determine the best treatment for you. This is known as precision medicine. The results can be available in as little as 7 days.

Should I have an InVisionFirst®-Lung liquid biopsy? 

InVisionFirst®-Lung is for individuals who have been diagnosed with aNSCLC. Ask your care team if InVisionFirst®-Lung is right for you.*

* A physician’s order is required for this test.

Supporting patient care through in-home and site blood draws, at no cost to you

NeoGenomics offers patients the option of site location or in-home blood draws through our National Mobile Phlebotomy Program to collect blood samples in a stress-free environment by a skilled phlebotomist. Contact a patient advocate today to learn more.

Email: patients@neogenomics.com

Phone: 866.776.5907, ext. 9

† A doctor's order is required for this service

Interested in InVisionFirst®-Lung for yourself or a loved one?

Our discussion guide can help you talk to your cancer care team about InVisionFirst®-Lung:

DOWNLOAD InVisionFirst®-Lung DISCUSSION GUIDE NOW

References:

  1. CancerNet. https://www.cancer.net/navigating-cancer-care/diagnosing-cancer/tests-a…. Accessed March 15, 2022.
  2. VanderLaan PA, et al. Cancer Cytopathol. 2021;129(3):179-181.

We're Here to Help

Have more questions about InVisionFirst®-Lung? Our Patient Advocate Team is here to help

Email: patients@neogenomics.com

Phone: 866.776.5907, ext. 9

A physician's order is required for this service.